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Background:  This  study  aims  to  determine  the  overall  prevalence  of  ocular  conditions  in  a
population  from  19  to  64  years  old,  presenting  with  refractive-based  symptoms  only.  Results
could impact  clinical  standard  of  eye  care  on  a  similar  population.
Methods:  This  is  a  retrospective  study  on  patients  seen  for  an  eye  examination  at  the  Clinique
Universitaire  de  la  Vision  (CUV),  between  January  2007  and  2009.  Files  of  individuals  who  pre-
sented with  refractive  symptoms  were  only  selected  and  classiﬁed  by  ﬁle  number.  Then,  every
third ﬁle  from  the  beginning  was  kept  and  reviewed  by  a  reader.  A  second  reader  did  the  same
with every  third  ﬁle  from  the  end.  Both  readers  were  trained  to  use  the  same  analysis  grid  to
classify the  diagnosed  ocular  conditions.  In  the  case  of  multiple  ﬁndings,  the  most  severe  condi-
tion was  considered.  The  overall  prevalence  of  ocular  conditions  was  determined  by  calculating
their occurrence  divided  by  the  number  of  ﬁles  analyzed.
Results:  A  total  of  860  charts  were  analyzed.  In  26.1%  of  the  cases  an  ocular  condition  was
diagnosed.  This  work  establishes  a  higher  prevalence  of  ocular  conditions  compared  to  another
study conducted  in  Canada  in  the  past.  This  difference  can  be  explained  by  a  different  analytical
methodology  and  by  the  fact  that  all  examinations,  in  this  study,  were  made  under  pupillary
dilation.
Conclusion:  The  presence  of  ocular  conditions  in  26%  of  asymptomatic  patients  supports  the
need to  assess  ocular  health  under  pupil  dilation  as  part  of  any  eye  examination.  However,
further cost-to-beneﬁt  analysis  is  required  before  establishing  such  a  recommendation.





Prevalencia  de  condiciones  patológicas  oculares  asintomáticas  en  pacientes  con
síntomas  refractivos
Resumen
Antecedentes:  Este  estudio  trata  de  determinar  la  prevalencia  general  de  las  condiciones
patológicas  oculares  en  una  población  de  pacientes  de  19  a  64  an˜os  de  edad,  que
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presentaron  únicamente  síntomas  refractivos.  Los  resultados  podrían  suponer  un  impacto  para
los estándares  clínicos  de  cuidado  ocular  en  poblaciones  similares.
Métodos:  Este  es  un  estudio  retrospectivo  sobre  pacientes  examinados  en  la  Clinique  Universi-
taire de  la  Vision  (CUV),  entre  Enero  de  2007  y  2009.  Se  seleccionaron  y  clasiﬁcaron  por  número
de archivo  aquellas  historias  de  pacientes  con  síntomas  refractivos  únicamente.  A  continuación
se seleccionó  cada  tercer  archivo  contando  desde  el  inicio,  el  cual  fue  revisado  por  un  mismo
lector. Un  segundo  lector  realizó  la  misma  operación  con  cada  tercer  archivo  contado  desde  el
ﬁnal. Ambos  lectores  fueron  formados  para  utilizar  la  misma  cuadrícula  analítica  para  clasiﬁcar
las condiciones  oculares  diagnosticadas.  En  caso  de  múltiples  hallazgos  se  consideró  la  situación
más severa.  Se  determinó  la  prevalencia  general  de  las  condiciones  oculares  mediante  el  cálculo
de su  ocurrencia,  dividida  por  el  número  de  archivos  analizados.
Resultados:  Se  analizó  un  total  de  860  historias.  En  el  26,1%  de  los  casos  se  diagnosticó  una
condición patológica  ocular.  Este  trabajo  establece  una  mayor  prevalencia  de  las  condiciones
patológicas  oculares  en  comparación  a  otro  estudio  realizado  en  Canadá  en  el  pasado.  Esta
diferencia puede  explicarse  por  el  uso  de  una  metodología  analítica  diferente  y  por  el  hecho  de
que todos  los  exámenes  de  este  estudio  se  realizaron  en  condiciones  de  dilatación  de  la  pupila.
Conclusión:  La  presencia  de  condiciones  patológicas  oculares  en  el  26%  de  los  pacientes  asin-
tomáticos  apoya  la  necesidad  de  evaluar  la  salud  ocular  como  parte  de  cualquier  examen  ocular.
Sin embargo,  se  hace  necesario  un  análisis  adicional  coste-beneﬁcio  antes  de  establecer  dicha
recomendación.
































































yThe  prevalence  of  common  speciﬁc  diseases  and  dis-
rders  is  well  known,1 at  least  in  developed  countries
here  public  health  data  are  collected.  First,  this  knowl-
dge  may  help  practitioners  to  consider  who  is  at  risk
mong  their  patients  and  to  better  diagnose  any  patholog-
cal  condition.2 For  example,  patients  over  50  years  old
re  routinely  screened  for  glaucoma  on  this  basis.  Sec-
nd,  it  helps  politicians  and  bureaucrats  to  shape  public
ealth  policies  and  to  estimate  for  the  cost  associated  with
he  management  of  speciﬁc  diseases.  Third,  prevalence
nalysis  can  help  universities  and  colleges  to  plan  the  num-
er  of  human  resources  to  train.  Fourth,  in  some  cases,
 higher  prevalence  of  a  speciﬁc  disease  can  encourage
ealthcare  system  administrators  to  put  a  better  screening
rogram  in  place,  or  to  adopt  a  new  treatment  strategy,
o  reduce  morbidity  and  disease-associated  costs.3 Sys-
ematic  screening  programs  for  diabetic  eye  disease  have
een  developed  in  many  countries  and  represent  a  good
xample  of  such  policies.  They  can  also  help  to  plan  tar-
eted  educational  campaigns  to  raise  public  awareness  in
rder  to  modify  their  behavior.4 For  example,  large-scale
urveys  in  the  U.S.  have  shown  that  only  11%  of  people
re  aware  that  diabetic  retinopathy  comes  with  no  ini-
ial  warning  symptoms  and  as  little  as  8%  for  open  angle
laucoma.5 Similarly,  clinical  research  on  rhegmatogenous
etinal  detachments  has  shown  that  approximately  1  patient
ut  of  3  (31.3%)  has  at  least  one  asymptomatic  retinal
nding  predisposing  to  retinal  detachment.6 In  such  cases,
ducating  patients  at  risk  may  prompt  early  detection,
hich  helps  limit  the  costs  and  negative  impact  of  the  dis-
ase.
To  this  point,  a  recent  study7 proved  that  a  substantial
urden  results  from  vision  loss  and  eye  disorders  in  the  U.S.
stimates  for  the  population  younger  than  40  years  of  age
re  $14.5  billion  US  in  direct  costs  and  $12.2  billion  US  in  lost




puality-adjusted  life  years  (QALYs).  This  adds  another  $10.8
illion  US,  bringing  the  total  cost  of  vision  loss  and  eye  dis-
rders  to  $37.5  billion  US$  or  $17,400  US  per  patient.
On  the  other  hand,  some  health  policies  are  apparently
ot  deﬁned  on  the  basis  of  cost-effectiveness  analysis.  For
xample,  in  2010  British  Colombia  (BC)  became  the  ﬁrst  and
till  the  only  jurisdiction  in  North  America  to  deregulate  its
ptical  market  in  response  to  the  industry’s  lobbying  efforts,
ith  no  evidence  of  any  public  health  beneﬁt.  This  decision
as  supposedly  made  to  lower  the  cost  of  goods,  but  with-
ut  evaluating  the  potential  impact  of  such  a  decision  on  eye
ealth.  Since  then,  individuals  aged  19--64  years  old  can  pur-
hase  their  glasses  and  contact  lenses  based  on  electronic
efraction  data  (sight  testing)  gathered  by  any  lay  person
elling  ophthalmic  lenses,  not  validated  as  a  prescription  by
n  eye  care  professional.  This  deregulation  implies  that,  in
his  jurisdiction,  a  complete  eye  exam,  including  ocular  dis-
ase  screening,  is  no  longer  required  to  obtain  new  glasses
r  contact  lenses.
It  is  hard  to  estimate  the  immediate  and  long  term
mpact  of  this  decision  because,  contrary  to  conﬁrmed  ocu-
ar  pathology,  there  is  very  limited  data  available  about  the
revalence  of  missed  pathologies  among  a  population  con-
ulting  for  sight  testing,  with  no  symptoms  other  than  those
efractive  in  nature.
However,  we  can  estimate  that  this  prevalence  increases
ith  time  and  aging  of  the  population.  In  fact,  it  is  known
hat  signiﬁcant  fundus  ﬁndings  in  patients  presenting  with
o  symptoms  increase  with  age.8 On  the  other  hand,  there
s  no  strong  evidence  that  dilated  fundus  examinations,  sys-
ematically  performed,  in  asymptomatic  younger  patients
ield  a  high  level  of  pathology  ﬁndings.9 This  is  the  reason
hy  the  recommended  eye  examination  schedule  becomes
ore  frequent  for  older  people,  although  no  one  knows  the





















































TPrevalence  of  asymptomatic  ocular  conditions  
Consequently,  this  study  aims  to  establish  the  prevalence
of  ocular  conditions  affecting  asymptomatic  individuals  for
a  cohort  including  younger  and  older  patients  between  19
and  64  years  of  age,  seeking  for  an  eye  exam  solely  based
on  refractive  symptoms.  The  second  aim  is  to  categorize  and
establish  the  prevalence  of  each  ocular  condition  diagnosed
in  the  course  of  their  eye  examination.  These  elements  are
important  because  they  could  impact  clinical  standards  of
eye  care  for  similar  populations.
Materials and methods
This  is  a  retrospective  study.  It  was  conducted  after  obtain-
ing  Institutional  Review  Board  approval  (Comité  d’éthique
de  la  recherche  en  sciences  de  la  santé  --  CERSS  --  Univer-
sité  de  Montréal,  Montréal,  Québec).  The  CUV  electronic
database  ﬁles  of  individuals  between  19  and  64  years  of  age
at  the  time  of  their  last  comprehensive  eye  exam,  between
January  2007  and  January  2010,  were  selected.  Files  of
individuals  with  a  positive  case  history  containing  previous
knowledge  of  ocular  pathology  or  the  presence  of  symptoms
suggesting  an  ocular  condition  were  excluded.  For  example,
people  known  to  have  cataracts  or  reporting  recent  occur-
rences  of  ﬂashes  and/or  ﬂoaters  were  excluded.  However,
it  is  possible  for  a  patient  to  present  with  refractive  symp-
toms  and  have  pathological  conditions,  such  as  a  cataract
inducing  myopia  increase,  unbeknownst  to  patient,  students
or  supervisor.  These  cases  were  obviously  included  because
their  symptoms  are  related  to  refraction  and  not  to  an
alarming  sign  of  an  ocular  pathology.  This  study  aims  to
identify  them.  With  the  same  rationale,  ﬁles  of  patient  with
high  myopia,  which  are  at  a  higher  risk  to  present  periph-
eral  conditions,  were  not  kept  if  the  patient  mentioned  this
risk  as  the  reason  to  consult.  On  the  other  hand,  ﬁle  of  a
high  myopic  patient  was  kept  for  analysis  if  the  patient  was
asymptomatic  and  not  knowledgeable  about  existing  reti-
nal  conditions,  and  if  the  eye  examination  was  initiated  on
the  basis  of  refractive  symptom  only.  Contact  lens  wearers
were  considered  only  if  they  were  asymptomatic  at  the  time
of  their  visit,  and  with  no  proven  record  of  anterior  segment
diseases  in  the  past.
As  suggested  by  the  public  health  department  experts  at
Université  de  Montréal,  study  candidates  were  selected  by
keeping  every  third  ﬁle  from  the  beginning  and  the  end  of
a  list,  containing  the  total  number  of  ﬁles  selected.  They
were  then  retrieved  and  split  between  two  readers  trained
to  use  the  same  analysis  grid.
File  analysis  is  simpliﬁed  by  the  fact  that  the  CUV  policy
manual  sets  standards  for  case  histories  and  eye  examina-
tions.  Examinations  were  performed  by  optometry  students
(4th  year)  under  the  supervision  of  certiﬁed  optometrists,
responsible  for  establishing  the  diagnosis  and  the  treatment
plan.  Clinicians  and  students  had  to  follow  the  procedures
and  guidelines  as  written.  The  examination  ﬁle  was  conse-
quently  standardized  for  every  visit  made.
The  ﬁrst  step  was  to  revise  the  selected  ﬁles  and  make
sure  that  subjects  were  asymptomatic  of  any  ocular  con-
ditions,  based  on  their  case  history,  except  for  refractive
symptoms.  This  included  a  careful  analysis  of  the  pre-exam
questionnaire  ﬁlled  in  by  the  patient  at  the  time  of  consul-




symptomatic,  the  second  step  was  to  identify  the  presence
f  an  ocular  condition,  on  the  basis  of  the  written  diagno-
is,  and/or  the  recommendations  made  to  the  patient  as
ecorded  and/or  any  action  taken  following  the  examination
treatment  prescribed,  follow-up  planned  or  referral  made).
or  example,  if  macular  drusen  or  a  variation  in  macular  pig-
entation  was  noted  in  the  ﬁle,  the  condition  would  be  only
onsidered  macular  degeneration  if  the  term  appeared  in
he  diagnosis  box  and/or  if  the  patient  education  was  done,
ncluding  risk  factor  identiﬁcation  and  written  recommen-
ations  (vitamins  supplements,  smoking  cessation,  Amsler
rid,  etc.).  The  same  rationale  was  applied  for  peripheral
etinal  ﬁndings:  a  tuft  or  lattice  degeneration  was  only  con-
idered  as  an  ocular  condition  following  patient  education
n  symptoms  of  retinal  detachment  and/or  if  a  further  fun-
us  exam  under  dilation  was  planned  to  control  evolution
f  the  condition.  The  presence  of  a  cataract  not  previously
nown  to  the  patient  was  also  considered  an  ocular  condi-
ion,  on  the  understanding  that  it  could  trigger  the  causative
ymptoms  (refractive-based)  for  seeking  out  an  eye  exami-
ation.
A  list  containing  all  conditions  that  can  be  screened  dur-
ng  a routine  eye  exam  was  provided  to  both  reviewers.
nce  identiﬁed,  the  condition  was  graded  (low-moderate-
evere).  Only  one  condition  per  ﬁle  (the  most  severe)  was
ept  for  further  analysis.  For  example,  if  a  patient  showed
ow  signs  of  ocular  dryness  (without  symptoms)  and  moder-
te  signs  of  dry  macular  degeneration,  the  latter  was  kept.
n  case  of  any  doubt,  the  ﬁrst  reviewer  would  ask  the  second
o  revise  the  chart  for  classiﬁcation  purposes.  Both  had  to
gree  on  the  presence  of  the  same  ocular  condition  and  its
everity  in  order  to  retain  the  ﬁle  for  analysis.  Lastly,  the
um  of  each  ocular  condition  was  calculated.  It  was  then
asy  to  determine  its  prevalence  based  on  the  total  number
f  ﬁles  analyzed.
tatistics
eans  and  standard  deviations  were  calculated  for  demo-
raphic  data.  The  prevalence  of  patients  for  whom  at  least
ne  asymptomatic  condition  was  found  was  calculated  and
ompared  to  the  only  study10 published  for  a  Canadian  pop-
lation  using  the  Chi-squared  method  (2).
esults
 total  of  2548  ﬁles  were  extracted  from  the  database,  rep-
esenting  all  of  the  individuals  seen  for  a  comprehensive  eye
xamination  between  2007  and  2009.  From  this  number,  115
les  were  rejected  because  of  incomplete  data.  Based  on
he  suggested  procedure,  a  total  of  846/2,433  (34.7%)  ﬁles
ere  then  processed.  This  cohort  was  composed  of  389  men
nd  497  women,  mostly  Caucasian  (69.2%),  aged  41.7  (±8.9)
ears.  A  majority  of  these  patients  (73.7%)  were  myopes
ith  a  mean  refractive  error  of  −3.65  (±2.27D),  including
6%  showing  a  low  level  of  astigmatism  (−0.87  ±  0.42D).
he  characteristics  of  this  cohort  are  comparable  to  the
resenting  population  of  the  clinic.
In  all,  220  individuals  presented  at  least  one  asymp-
omatic  ocular  condition  (26.1%  of  the  ﬁles  analyzed).
etinal  conditions  were  the  most  common  (13.7%),  followed
156  
Table  1  List  of  ocular  conditions  as  found  during  routine
eye  examination  on  asymptomatic  patients.






closure  glaucoma  suspect  (narrow
angles)
4.9
Blepharitis,  dry  eye  syndrome  2.9
Mass, suspicious  lesion  in  the  fundus
(naevus,  etc.)
2.7
Macular  degeneration  or  other
maculopathy
1.9
Pathology  related  to  contact  lenses  1.2
Suspicious  lesion  of  adnexa  or  lids  1.1
Cataracts,  intra-ocular  lens  opacities  0.9
Hypertensive  and  diabetic  retinopathy  0.9
Anterior  segment  dystro-
phy/degenerations/conjunctivitis
0.8

























































































cOptic  neuropathy  (non  related  to
glaucoma)
0.5
y  glaucoma/ocular  hypertension  (4.9%),  dry  eye  (2.9%)  and
nterior  segment  diseases  (3.1%).  The  prevalence  of  asymp-
omatic  conditions  is  detailed  in  Table  1.
iscussion
n  order  to  interpret  our  results,  we  would  underscore  that
he  deﬁnition  of  asymptomatic  conditions  can  differ  from
ne  study  to  another  and,  consequently,  results  can  be  dif-
cult  to  compare.  Contrary  to  our  approach  in  this  study,  it
ould  be  argued  that  refractive  error  change,  per  se,  can
e  considered  a  symptom/sign  of  certain  ocular  condition,
nd  some  authors  may  exclude  subjects  based  on  this  argu-
ent.  For  example,  cataracts  will  develop  with  an  increase
n  myopia.  Although  we  know  this  is  true,  if  the  patient
s  unaware  of  the  condition,  the  consultation  can  be  con-
idered  that  concerns  only  refractive  reasons.  We  aimed
o  identify  pathology  or  ocular  conditions  in  patients  ask-
ng  for  a  vision  test  or  attending  to  change  their  glasses
nd  ignoring  that  they  have  an  ocular  health  problem.  We
elieve  that  our  approach  will  help  identify  the  risk  of  miss-
ng  a  pathology  during  patient  sight  testing.  On  the  other
and,  our  study  does  not  include  patients  who  are  totally
symptomatic  (no  symptoms  at  all,  we  consider  the  refrac-
ive  symptoms)  because  they  are  rarely  seen  on  a routine
asis  in  an  optometry  clinic.  Our  population  was  composed
f  individuals  consulting  on  their  refractive  needs  only,  and
ur  results  should  be  interpreted  accordingly.  Because  of
he  nature  of  the  ocular  conditions  found,  we  believe  that
ur  results  can  be  applied  elsewhere,  with  a  similar  popula-
ion.
According  to  these  ﬁndings,  one  out  of  four  patients
resenting  with  an  ocular  condition  not  known  to  him/her
erits  immediate  treatment,  follow-up  or  a  referral  to
c
ﬁ
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nother  health  care  practitioner.  This  prevalence  is  higher  if
ompared  to  the  results  of  another  study10 made  in  Canada
n  2003  where  the  author  found  that  ocular  disease  was
resent  in  14.4%  of  the  patients.  With  respect  to  this  study,
he  total  prevalence  of  asymptomatic  ocular  conditions
ound  in  our  series  is  statistically  higher  (26.1%  vs.  14.4%;
 = 0.0025).  In  another  study,  other  authors  found  an  over-
ll  prevalence  of  undetected  eye  disease  of  16.67%11 in  a
ifferent  population.
Several  elements  can  explain  the  deviations  from  the
ther  Canadian  study  (see  Table  2).  First  of  all,  the  popula-
ion  studied  was,  in  that  case,  younger  than  ours.  In  general,
he  prevalence  of  ocular  conditions  increases  with  age.  Sec-
nd,  the  time  spent  on  performing  an  eye  examination  is
onger  in  a  university  setting  (average  of  2  h/patient  vs.
0  min/patient),  thus  allowing  for  more  extensive  testing  of
he  patient.  From  that  perspective,  the  most  important  fac-
or  is  certainly  that  fundus  evaluation  is  made  under  pupil
ilation,  using  fundus  lenses  with  binocular  indirect  oph-
halmoscope  and  slit  lamp.  This  testing  was  done  on  every
atient,  as  it  is  the  policy  for  every  patient  consulting  at  U.
e  Montréal,  which  was  not  the  case  in  the  other  study.  At
hat  time,  more  than  10  years  ago,  routine  dilation  was  not
sed  as  a  regular  practice  in  optometric  ofﬁces  in  Canada,
s  it  is  today.  An  increased  amount  of  ocular  ﬁndings  in
he  peripheral  retina,  such  as  lattice  degeneration,  reti-
al  holes,  vitreo-retinal  tufts  and  choroidal  naevi  requiring
ollow-up  is  certainly  to  be  expected  when  dilation  becomes
 standard  care  practice.  If  the  fundus  assessment  is  made
ithout  dilation,  peripheral  retinal  conditions  can  be  easily
issed.  In  one  study,  the  authors  proved  that  of  32  poste-
ior  pole  anomalies  that  required  action,  38%  were  missed
uring  the  natural  pupil  examination.  Moreover,  more  than
alf  of  abnormal  conditions  not  requiring  immediate  action
ere  also  missed.12 One  other  author6 rated  the  prevalence
f  peripheral  retinal  conditions  needing  close  follow-up  or
eferral  to  an  ophthalmologist  at  8%,  consistent  with  the
ndings  of  the  present  study  (7.74%).  In  both  studies,  dila-
ion  was  performed  with  every  patient,  which  was  not  the
ase  for  Robinson  et  al.,  who  estimated  this  prevalence  at
nly  1.35%.  The  overall  difference  between  our  ocular  ﬁnd-
ngs  and  those  of  Robinson  can  be  largely  explained  by  the
act  that  peripheral  retinal  problems  remained  occulted  in
he  latter.
Third,  examination  was  made  by  an  optometry  student
4th  year)  but  controlled  and  checked  by  an  experienced
ptometrist.  This  duplication  in  testing  lowers  the  risks  of
issing  an  ocular  condition.  Finally,  the  other  study  was
ased  on  a multi-analysis  of  ﬁles  gathered  at  133  sites,
ach  with  its  own  rules  and  practices.  In our  case,  all  of
he  exams  were  conducted  and  recorded  under  the  same
ractice  guidelines  and  with  the  same  ﬁle  template,  leading
o  a  more  standardized  procedure.  Unfortunately,  read-
rs  did  not  identify  the  number  of  different  clinicians  and
tudents  involved  in  the  process.  Because  students  and  cli-
icians  adhere  to  the  same  standards,  we  do  not  believe
hat  this  represents  a  signiﬁcant  factor  likely  to  alter  our
onclusions.These  results  could  impact  the  clinical  standards  of  eye
are  in  Canada  and  elsewhere.  Speciﬁcally,  based  on  our
ndings,  the  current  practice  in  British  Columbia  or  in  other
urisdictions  around  the  world,  where  non-professionally
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Table  2  Differences  between  the  present  study  and  the  Robinson  et  al.  study.
Robinson  et  al.1 Present  study




Reason for  consultation  All  Only  routine  exam  for  refractive
purpose
Deﬁnition of  asymptomatic  Not  having  prior  knowledge  of  the
presence  of  the  disease
Not  having  symptoms  associated  with
the disease  and  not  having  prior
knowledge  of  the  presence  of  the
disease
Ages All  19--64  years  of  age
Testing made Refractive  examination  and  ocular
health  screening.  Fundus  exam  under
dilation  is  made  in  the  presence  of
risk  factors  or  symptoms  (not  made
on every  patient)
Comprehensive  eye  exams:
Refraction,  ocular  health  screening,
binocular  vision,  automated  visual





























Ttrained  individuals  could  prescribe  glasses  and  contact
lenses,  may  lead  to  the  non-diagnosis  of  signiﬁcant  ocular
pathologies  that  are  vision  and  sight  threatening.  Compre-
hensive  eye  exams,  including  ocular  health  assessments,
remain  one  of  the  practitioner’s  most  important  tools  in
preventing  disease.13 Optometrists  can  play  a  key  role  in
any  public  health  system  by  offering  opportunistic  detec-
tion  of  ocular  disease  in  asymptomatic  patients  consulting
for  refractive  problems.14
Our  data  highlight  the  importance  of  incorporating
dilated  fundus  examination  as  a  routine  procedure  during
eye  examinations  of  asymptomatic  patients,  despite  rare
but  existing  consequences,  such  as  ocular  irritation,  allergy
to  the  drugs  used  to  dilate  the  pupil,  the  potential  to  induce
angle-closure  glaucoma  and  the  transient  effect  of  the  pro-
cedure  on  the  patient’s  vision.  As  shown,  a  dilated  fundus
assessment  could  lead  to  early  detection  of  ocular  condi-
tions  and,  eventually,  help  reduce  morbidity  and  the  costs
associated  with  eye  diseases.  Consequently,  it  would  not  be
considered  good  practice  to  conduct  a  sight  testing  without
assessing  ocular  health  at  the  same  time.  This  could  leave
the  patient  at  risk  of  eye  diseases.
Does  that  mean  that  every  single  asymptomatic  patient
should  be  assessed  for  ocular  disease?  Obviously,  the  answer
is  yes,  although  the  frequency  of  such  exams  has  yet  to  be
determined.  Some  evidence  shows  that  clinically  signiﬁcant
ocular  conditions  increase  with  age.15 For  that  reason,  opto-
metric  and  ophthalmology  regulatory  bodies  recommend
periodic  eye  examination,  although  there  is  no  consensus
on  the  optimal  moment  to  assess  patients.
Part  of  the  problem  is  that  this  type  of  recommenda-
tion/regulation  should  be  analyzed  through  a  cost-beneﬁt
ratio  approach.  Health  agencies  and  politicians  must  con-
sider  these  factors  before  adopting  or  modifying  regulations
and  policies  related  to  eye  care  and  the  optical  market,  to
establish  recommendations  concerning  the  optimal  sched-
ule  for  comprehensive  eye  examinations,  and  to  determine




iBased  on  the  fact  that  vision  loss  and  eye  disorders  can
ost  $17,500  US  per  patient,  as  already  mentioned,  and  esti-
ating  the  cost  of  a  comprehensive  exam  at  $100  US  per
atient,  it  is  readily  apparent  that  public  health  system  cov-
rage  of  a  comprehensive  eye  examination  is  proﬁtable.  For
xample,  take  an  individual  20  years  old  who  is  seen  by  an
ptometrist  every  2  years  up  to  the  age  of  65  and  every  year
hereafter,  with  a  life  expectancy  of  85  years  of  age.  This
mplies  42  eye  exams  throughout  his  life  for  a  total  cover-
ge  cost  of  $4200  US.  Based  on  our  ﬁndings,  26.1%  of  the
opulation  has  an  ocular  condition  or  an  eye  disorder  that
ould  potentially  lead  to  a  vision  impairment  or  loss.  This
eans  that  for  every  four  patients  we  see,  we  will  detect
nd  screen  one  problematic  case.  The  total  cost  of  such  a
creening  (4  ×  $4200  US)  is  still  less  than  the  cost  of  a  single
ase  of  an  eye  disorder  ($17,500  US).  However,  this  evalu-
tion  is  only  valid  if  we  admit  that  early  detection  always
revents  the  development  of  a  vision  loss.
onclusion
n  conclusion,  about  1  in  4  patients  (26.1%)  between  the  ages
f  19  and  64,  consulting  with  refractive-based  symptoms
nly,  present  with  at  least  one  asymptomatic  ocular  condi-
ion  that  requires  treatment,  referral  to  another  health
rofessional,  careful  follow-up  or  patient  education.  This
nderscores  the  importance  of  assessing  ocular  health,
deally  under  pupil  dilation,  at  the  same  time  that  the
efractive  examination  is  performed.
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ADDRESS DATE OF BIRTH   (day / month /  year)                                          AGE......................
CITY OCCUPATI ON
POSTAL CODE TELEPHONE#
WORK                  : (          )
HOME                   : (          )
REASON FOR CONSULTING  
You   are consultin g because ...
• It is time for your routine examination ..... ...................... .......... ............... ...... .......... ....... ..... .....................Yes 0 No 0 I do not know  0  
Yes 0 No 0 I do not know  0  
Yes 0 No 0 I do not know  0  
Yes 0 No 0 I do not know  0  
Yes 0 No 0 I do not know  0  
Yes 0 No 0 I do not know  0  
Yes 0 No 0 I do not know  0  
Yes 0 No 0 I do not know  D
Yes 0 No 0 I do not know  D
Yes 0 No D I do not know  0
• Blurred distance vision .. ... ...................... .......... ............ ................... ....... ..... ...............................................
• Blurred near vision (reading) .. ... ...................... .......... ............ ......... .......... ....... ..... .....................................  
• You experience double vision ..................................................................................................................  
• You experience eyestrain .. ... ...................... .......... ............ ................... ....... ..... ...........................................  
• One  eye  turns in or ou t .. ... ...................... .......... ............ ................... ....... ..... ................................................
• You have  one of the  followin g sym ptom s:
• ltchiness . ... ......................... ...................... ....................... ........... ............. ...... ...... ......... .................... .   
• Dryness . ... ......................... ...................... ....................... ........... ............. ...... ...... ......... .................... ..
• Pressure .... ......................... ...................... ....................... ........... ............. ...... ...... ......... .................... .
• Redness . ... ......................... ...................... ....................... ........... ............. ...... ...... ......... .................... . 
• Burning sensation . ... ......................... ...................... ....................... ..... ...... ............. ...... ...... .............. .  Yes 0 No 0 I do not know  D
·             • Glare ....... .................................. ........................ ....................... ................. ..... ............................ ....... Yes 0 No D I do not know  D
• Tearing  ............................ ........................ ....................... .................................... ........................ ..... Yes 0 No 0 I do not know  D
• You have headaches /migraines on a regular basis  .......................... ........ ........... ...... ..... .........................   Yes 0 No 0 I do not know  0
• Your eyes fatigue easily ........................................................................................................................  Yes D No D I do not know D 
• You  have noticed  one of the  following  phenomena:  
•  Flas hing light ...................................................................................................................................  Yes 0 No D I do not know  D 
• Distorted vision  .................. ..................... .........................................................................................  Yes 0 No 0 I do not know  D 
• Night vision problems  ........ ..................................................................................................... .......   Yes 0 No 0 I do not know  D 
• Loss of visual field . .... ..... ......... ..........................................................................................................   Yes D No 0 I do not know  D 
• Change in color vision . .... ..... ......... ..................................................................................................  Yes 0 No 0 I do not know  D 
• Other: ...................................................................................................................................  
Do you wear glasses ? .. ... ...................... .......... ............ ................................................. ... ..... .....................  Yes D No 0 I do not know  D 
• If yes...do you wish to change them? ......................................................................................... ... .   Yes D No D I do not know  D 
• If no...have you ever wom any?.......................................................................................................     Yes 0 No D I do not know  D 
/           /
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Do you wear contact lenses? ...................................................................................... Yes 0 No 0 I do not know 0  
Yes 0 No 0 I do not know 0  
Yes 0 No 0 I do not know 0  
• If no...do you want any? ........................................................................................................                  
• If no...have you ever worn any? ...........................................................................................   
ABOUT YOUR EYES  
Do you or a family member suffer from   (or has suffered from  )
• Cataracts Yourself Family  member
Yes 0  No 0 I do not know  0  Yes 0 No 0 I do not know 0
• Glaucoma (high eye pressure) Yes 0  No 0 I do not know  0  Yes 0 No 0 I do not know 0
• Lazy eye ( amblyopia, strabismus) Yes 0  No 0 I do not know  0  Yes 0 No 0 I do not know 0
• Retinal  problems Yes 0  No 0 I do not know  0  Yes 0 No 0 I do not know 0
• Comeal problems Yes 0  No 0 I do not know  0  Yes 0 No 0 I do not know 0
Yes 0 No 0 I do not know 0• Partial or complete blindness
• Other
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0  No 0 I do not know  0  
Yes 0 No 0 I do not know 0
Yes 0 No 0 I do not know 0
Yes 0 No 0 I do not know r
Yes 0 No 0 I do not know 0
• Do you use eye drops ?.......................................................................................................................
• Were you ever prescribed any ? .........................................................................................................
• Have you ever done visual training ? .................................................................................................  
• Have you ever had an eye injury, disease or operation ? ...................................................................   
ABOUT YOUR HEALTH  
Do you or  a family member suffer from (or  has suffered from)    
Yourself       Family member
• Hypertension (high blood pressure) 
   Diabetes
   Cardiac problems (heart problems)
   Kidney problems
   Pulmonary problems
   Liver problems
   Other
• Are you currently on any medication prescribed by a doctor................................................................ 
or purchased without a prescription ?.......................................................................... 
• Have you ever taken any medication over a long period of time ?................................................  
• Do you have any allergies ? (including to medication) ................................................................. 
YOUR LAST EYE EXAMINATION 
When was your last eye examination ?......................................................................................................Yes 0  No 0 I do not know  0  Was it done at the Montreal School of Optometry Clinic ?....................................................................... 
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